Peripheral T-cell lymphomas are a group of rare neoplasms originating from clonal proliferation of mature post-thymic lymphocytes with different entities having specific biological characteristics and clinical features. As natural killer cells are closely related to T-cell, natural killer-cell lymphomas are also part of the group. The current World Health Organization classification recognizes four categories of T/natural killer-cell lymphomas with respect to their presentation: disseminated (leukemic), nodal, extranodal and cutaneos. Geographic variations in the distribution of these diseases are well documented: nodal subtypes are more frequent in Europe and North America, while extranodal forms, including natural killer-cell lymphomas, occur almost exclusively in Asia and South America. On the whole, T-cell lymphomas are more common in asia than in western countries, usually affect adults, with a higher tendency in men, and, excluding a few subtypes, usually have an aggressive course and poor prognosis. Apart from anaplastic lymphoma kinase-positive anaplastic large cell lymphoma, that have a good outcome, other nodal and extranodal forms have a 5-year oversall survival of about 30%. According to the principal prognostic indexes, the majority of patients are allocated to the unfavorable subset. In the past, the rarity of these diseases prevented progress in the understanding of their biology and improvements in the efficaciousness of therapy. Recently, international projects devoted to these diseases created networks promting investigations on T-cell lymphomas. These projects are the basis of forthcoming cooperative, large scale trials to detail biologic characteristics of each sub-entity and to possibly individuate targets for new therapies.

T-cell lymphoma in South America and Europe / Bellei, Monica; Chiattone, C. S.; Luminari, Stefano; Pesce, Emanuela Anna; Cabrera, M. E.; de Souza, A. C.; Gabùs, R.; Zoppegno, L.; Milone, J.; Pavlovsky, A.; Connors, J. M.; Foss, F. M.; Horwitz, S. M.; Liang, R.; Montolo, S.; Pileri, S. A.; Polliak, A.; Vose, J. M.; Zinzani, P. L.; Zucca, E.; Federico, Massimo. - In: REVISTA BRASILEIRA DE HEMATOLOGIA E HEMOTERAPIA. - ISSN 1516-8484. - ELETTRONICO. - 34 (1):(2012), pp. 42-47. [10.5581/1516-8484.20120013]

T-cell lymphoma in South America and Europe.

BELLEI, Monica;LUMINARI, Stefano;PESCE, Emanuela Anna;FEDERICO, Massimo
2012

Abstract

Peripheral T-cell lymphomas are a group of rare neoplasms originating from clonal proliferation of mature post-thymic lymphocytes with different entities having specific biological characteristics and clinical features. As natural killer cells are closely related to T-cell, natural killer-cell lymphomas are also part of the group. The current World Health Organization classification recognizes four categories of T/natural killer-cell lymphomas with respect to their presentation: disseminated (leukemic), nodal, extranodal and cutaneos. Geographic variations in the distribution of these diseases are well documented: nodal subtypes are more frequent in Europe and North America, while extranodal forms, including natural killer-cell lymphomas, occur almost exclusively in Asia and South America. On the whole, T-cell lymphomas are more common in asia than in western countries, usually affect adults, with a higher tendency in men, and, excluding a few subtypes, usually have an aggressive course and poor prognosis. Apart from anaplastic lymphoma kinase-positive anaplastic large cell lymphoma, that have a good outcome, other nodal and extranodal forms have a 5-year oversall survival of about 30%. According to the principal prognostic indexes, the majority of patients are allocated to the unfavorable subset. In the past, the rarity of these diseases prevented progress in the understanding of their biology and improvements in the efficaciousness of therapy. Recently, international projects devoted to these diseases created networks promting investigations on T-cell lymphomas. These projects are the basis of forthcoming cooperative, large scale trials to detail biologic characteristics of each sub-entity and to possibly individuate targets for new therapies.
34 (1)
42
47
T-cell lymphoma in South America and Europe / Bellei, Monica; Chiattone, C. S.; Luminari, Stefano; Pesce, Emanuela Anna; Cabrera, M. E.; de Souza, A. C.; Gabùs, R.; Zoppegno, L.; Milone, J.; Pavlovsky, A.; Connors, J. M.; Foss, F. M.; Horwitz, S. M.; Liang, R.; Montolo, S.; Pileri, S. A.; Polliak, A.; Vose, J. M.; Zinzani, P. L.; Zucca, E.; Federico, Massimo. - In: REVISTA BRASILEIRA DE HEMATOLOGIA E HEMOTERAPIA. - ISSN 1516-8484. - ELETTRONICO. - 34 (1):(2012), pp. 42-47. [10.5581/1516-8484.20120013]
Bellei, Monica; Chiattone, C. S.; Luminari, Stefano; Pesce, Emanuela Anna; Cabrera, M. E.; de Souza, A. C.; Gabùs, R.; Zoppegno, L.; Milone, J.; Pavlovsky, A.; Connors, J. M.; Foss, F. M.; Horwitz, S. M.; Liang, R.; Montolo, S.; Pileri, S. A.; Polliak, A.; Vose, J. M.; Zinzani, P. L.; Zucca, E.; Federico, Massimo
File in questo prodotto:
File Dimensione Formato  
rbhh-34-042.pdf

accesso aperto

Tipologia: Versione dell'editore (versione pubblicata)
Dimensione 466.67 kB
Formato Adobe PDF
466.67 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11380/737452
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 31
  • ???jsp.display-item.citation.isi??? ND
social impact